Shigella spp. with reduced azithromycin susceptibility, Quebec, Canada, 2012-2013

Emerging Infectious Diseases

Volumn 20, Issue 5, 2014, Pages 854-856

  Gaudreau, Christiane ^a,b,d   Barkati, Sapha ^a,b   Leduc, Jean Michel ^a,b   Pilon, Pierre A ^a,b,c   Favreau, Julie ^a   Bekal, Sadjia ^a,b,d  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c Direction de sante publique de l'Agence de la sante et des services sociaux de Montreal   (United States)

^d INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZITHROMYCIN; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; MACROLIDE 2 PHOSPHOTRANSFERASE; NALIDIXIC ACID; PHOSPHOTRANSFERASE; TETRACYCLINE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; MACROLIDE 2'-KINASE;

ADULT; ARTICLE; CANADA; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE TRANSMISSION; DISK DIFFUSION; DRUG SENSITIVITY; EPSILOMETER TEST; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; SEXUALLY TRANSMITTED DISEASE; SHIGELLA; SHIGELLOSIS; VIRUS LOAD; ANTIBIOTIC RESISTANCE; BACTERIAL GENE; COINFECTION; DRUG EFFECTS; DYSENTERY, BACILLARY; EPIDEMIOLOGY; GENETICS; HEALTH SURVEY; MALE HOMOSEXUALITY; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED;

ADULT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; COINFECTION; DRUG RESISTANCE, BACTERIAL; DYSENTERY, BACILLARY; FEMALE; GENES, BACTERIAL; HOMOSEXUALITY, MALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PUBLIC HEALTH SURVEILLANCE; QUEBEC; SEXUALLY TRANSMITTED DISEASES; SHIGELLA;

EID: 84898861262     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2005.130966     Document Type: Article

References (15)

1. DuPont HL. Shigella species (bacillary dysentery). In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases, 7th ed. Philadelphia: Elsevier Churchill Livingstone; 2010. p. 2905-10.
2. Gaudreau C, Bruneau A, Ismaïl J. Outbreak of Shigella flexneri and Shigella sonnei enterocolitis in men who have sex with men, Québec, 1999 to 2001. Can Commun Dis Rep. 2005;31:85-90.
3. Gaudreau C, Ratnayake R, Pilon PA, Gagnon S, Roger M, Lévesque S. Ciprofloxacin-resistant Shigella sonnei among men who have sex with men, Canada, 2010. Emerg Infect Dis. 2011;17:1747-50. http://dx.doi.org/10.3201/eid1709.102034
4. American Academy of Pediatrics. Shigella infections. In: Pickering LK, Baker CJ, Kimberlin DW, Long SS, editors. Red book, 2012 Report of the Committee on Infectious Diseases, 29th ed. Elk Grove Village (IL): The Academy; 2012. p. 645-7.
5. World Health Organization. Guidelines for the control of shigellosis, including epidemics due to Shigella dysenteriae type 1. Geneva: The Organization; 2005.
6. Khan WA, Seas C, Dhar U, Salam MA, Bennish ML. Treatment of shigellosis: V. Comparison of azithromycin and ciprofloxacin. Ann Intern Med. 1997;126:697-703. http://dx.doi.org/10.7326/0003-4819-126-9-199705010-00004
7. Howie RL, Folster JP, Bowen A, Barzilay EJ, Whichard JM. Reduced azithromycin susceptibility in Shigella sonnei, United States. Microb Drug Resist. 2010;16:245-8. http://dx.doi. org/10.1089/mdr.2010.0028
8. Nataro JP, Bopp CA, Fields PI, Kaper JB, Strockbine NA. Escherichia, Shigella, and Salmonella. In: Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnock DW, editors. Manual of clinical microbiology, 10th ed. Washington (DC): American Society for Microbiology; 2011. p. 603-26.
9. Ewing WH. The genus Shigella. In: Ewing W, Edwards PR, editors. Edwards and Ewing's identification of Enterobacteriaceae, 4th ed. New York: Elsevier Scientific Publishing Co., Inc.; 1986. p. 135-72.
10. Ribot EM, Fair MA, Gautom R, Cameron DN, Hunter SB, Swaminathan B, et al. Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella and Shigella for PulseNet. Foodborne Pathog Dis. 2006;3:59-67. http://dx.doi.org/10.1089/fpd.2006.3.59
11. Ojo KK, Ulep C, Van Kirk N, Luis H, Bernardo M, Leitao J, et al. The mef(A) gene predominates among seven macrolide resistance genes identified in gram-negative strains representing 13 genera, isolated from healthy Portuguese children. Antimicrob Agents Chemother. 2004;48:3451-6. http://dx.doi.org/10.1128/AAC.48.9. 3451-3456.2004
12. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 23th informational supplement; no. M100-S23, vol. 33, no. 1. Wayne (PA): The Institute; 2013.
13. Sjölund Karlsson M, Bowen A, Reporter R, Folster JP, Grass JE, Howie RL, et al. Outbreak of infections caused by Shigella sonnei with reduced susceptibility to azithromycin in the United States. Antimicrob Agents Chemother. 2013;57:1559-60. http://dx.doi. org/10.1128/AAC.02360-12
14. Boumghar-Bourtchai L, Mariani-Kurkdjian P, Bingen E, Filliol I, Dhalluin A, Ifrane SA, et al. Macrolide-resistant Shigella sonnei. Emerg Infect Dis. 2008;14:1297-9. http://dx.doi. org/10.3201/eid1408.080147
15. Centers for Disease Control and Prevention. Outbreak of infections caused by Shigella sonnei with decreased susceptibility to azithromycin-Los Angeles, California, 2012. MMWR Morb Mortal Wkly Rep. 2013;62:171.